Perspectives on Medical Reimbursement By JR Associates Recently, our VP of Global Health Policy, Jo Ellen Slurzberg moderated a compelling roundtable discussion at MDG Boston, a leading member-based community for medical device and technology professionals. This session focused on one of the industry’s most formidable issues: U.S. Healthcare Economics – Innovating Our Way Out of a…
Perspectives on Medical Reimbursement By JR Associates Among our consultants, the MDMA Coverage, Reimbursement and Health Policy Conference is more than just another event on the business calendar. For us, it is an important professional tradition that began 21 years ago. That’s when our President, Judy Rosenbloom, and VP of Global Health Policy, Jo Ellen…
Perspectives on Medical Reimbursement By JR Associates In today’s highly complex healthcare environment, what’s the best way to prepare the next generation of life science innovators? This central question is often top-of-mind among members of the Global Educators Network for Health Innovation Education (GENiE Group). It also provides an overarching framework for the GENiE annual…
Perspectives on Medical Reimbursement By JR Associates What should medical device researchers know about premarket FDA submissions? And what should they understand about reimbursement in early stages of product development? These core questions inspired the first educational seminar hosted by ReGARDD (Regulatory Guidance for Academic Research of Drugs and Devices) in April 2017, where our…
Perspectives on Medical Reimbursement By JR Associates Coverage. Coding. Payment. These three factors deeply influence reimbursement for every new medical technology product. But there are no “cookie cutter” solutions. Because the reimbursement landscape is so complex and time consuming, it’s smart to start preparing for reimbursement as early as possible in the business planning and product development process. But…
Outsourcing Partner Speeds Entry Into Commercial Cancer Detection and Treatment Market Albuquerque, N.M. — (Business Wire), June 30, 2004 — Biomoda, Inc. announced today that it has contracted with reimbursement consulting firm, JR Associates, to help advance Biomoda’s patented biopharmaceutical products. Primarily, JR Associates consultants will investigate the potential for securing positive coverage, coding, and payment by Medicare and commercial…
